JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details


131 Mon, 8/1/2011, 8:30 AM - 10:20 AM CC-B114
Topics with Noninferiority and Equivalence Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Farid Kianifarid, Novartis
8:35 AM Noninferiority Margin for Longitudinal Data: The Timolol Ophthalmic Solution Example Rima Izem, U.S. Food and Drug Administration/CDER
8:50 AM A More Powerful Test Based on Ratio Distribution for Retention Noninferiority Hypothesis Ling Deng, Johnson & Johnson Pharmaceutical R&D, LLC ; Gang Chen, Johnson & Johnson Pharmaceutical R&D, LLC
9:05 AM Justification of Noninferiority Design in Infection Disease Studies Chunzhang Wu, Astellas Pharma Global Development, Inc.
9:20 AM Statistical Considerations in Assessing Assay Sensitivity in a Noninferiority Trial Isaac Nuamah, Johnson & Johnson Pharmaceutical R&D, LLC
9:35 AM Unifying Frequentist and Bayesian Approaches in Noninferiority Testing Mark A. Gamalo, U.S. Food and Drug Administration/CDER/OTS/OB ; Ram C. Tiwari, U.S. Food and Drug Administration/CDER/OTS/OB
9:50 AM Floor Discussion



2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.